This article is more than 5 years old. Information may no longer be current.
Novo Nordisk diabetes program receives certification
Click Here to Manage Email Alerts
Novo Nordisk recently received disease management certification in program design from the National Committee for Quality Assurance for its diabetes education program, according to a company press release.
“Earning [National Committee for Quality Assurance] disease management certification indicates that a disease management program excels in the specific area in which it was reviewed, program design, patient outreach or disease management systems,” Margaret E. O’Kane, president of the National Committee for Quality Assurance (NCQA), said in the release. “It’s an accomplishment to be proud of.”
Novo Nordisk’s diabetes education program is now certified for 2 years as a program that provides quality educational support to health care providers and patients. It also meets the review of the NCQA disease management program design standards.
The certification is meant to help organizations “achieve the highest level of performance possible, reduce patient risk and create an environment of continuous improvement,” according to the release. The program was evaluated for 68 elements in five categories including:
- Evidence-based guidelines;
- Patient services;
- Provider programs;
- Program marketing;
- Operation and measurement of quality improvement efforts.
“Novo Nordisk is proud to receive the NCQA disease management certification in program design,” Patricia Bradley, vice president of diabetes marketing at Novo Nordisk, said in the release. “The process was a rigorous evaluation of our entire [diabetes education program] and our approach to disease management. This certification underscores Novo Nordisk’s commitment to provide patients and health care providers with quality resources that will help improve patient care.”